Nutrition support and clinical outcomes following allogeneic stem cell transplantation

Nutrition support is frequently required post allogeneic stem cell transplantation (SCT) and while there is some evidence on the benefits of enteral nutrition (EN), parenteral nutrition (PN) is widely used in practice. The study aimed to examine the impact of EN versus PN on early outcomes following SCT. All patients who underwent allogeneic SCT over 2.5 years were included in the analysis. Data was retrospectively collected on mode of nutrition support with clinical outcome data obtained from an existing database. Clinical outcomes were compared between groups by logistic, poisson and negative binomial regression, with adjustment for baseline confounders as appropriate. Patients who received EN then changed to PN had a longer length of hospital stay compared to those who received EN only (IR 1.24, 95% CI: 1.11–1.38, p < 0.001). Compared to those who received EN only, patients who received EN that changed to PN or PN only had a longer time to neutrophil engraftment (IR 1.11, 95% CI: 1.02–1.20, p = 0.016 and IR 1.16, 95% CI: 1.03–1.30, p = 0.017) and platelet engraftment (IR 1.20, 95% CI 1.08–1.33, p < 0.001 and IR 1.24, 95% CI 1.08–1.42, p = 0.002). Enteral nutrition should be first line nutritional support for patients undergoing allogeneic SCT.